Neil Gunn

Recognized industry expert, Dr Gunn has spent 12 years at Roche Diagnostics, where he led the launches of well over one hundred products. He was also responsible for building Roche’s sequencing business, demonstrating above market performance and growing the team by more than 500 percent. Previously, Gunn spent eight years at Chiron Blood Testing, where he introduced the first molecular tests for blood screening (HIV and HCV) that are now standard practice around the world. More recently Dr Gunn has served as CEO of infectious disease company IDbyDNA, to its acquisition by Illumina.